Skip to main content
DONGSUNG PHARMACEUTICAL CO.,LTD logo

DONGSUNG PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002210 ISIN · KR7002210003 KO Manufacturing
Open in API
Filings indexed 367 across all filing types
Latest filing 2026-04-10 Major Shareholding Noti…
Country KR South Korea
Listing KO 002210

About DONGSUNG PHARMACEUTICAL CO.,LTD

http://dongsung-pharm.com/user-english/

Dongsung Pharmaceutical Co., Ltd., established in 1957, develops, manufactures, and markets a diverse range of products across pharmaceuticals, cosmetics, and hair care. The company's pharmaceutical division produces over-the-counter (OTC) drugs and is expanding into health functional foods. Its portfolio also includes a variety of cosmetic products and is particularly known for its hair dyes. Dongsung Pharmaceutical focuses on developing nature-friendly products and is engaged in advanced research, including photodynamic therapy (PDT) for potential cancer treatments.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a Korean “주식등의 대량보유상황보고서(약식)” – a detailed large shareholding status report including share counts, ownership changes, special relationships, and reasons for variation. This matches the Major Shareholding Notification category (crossing thresholds or reporting significant holdings). It is not merely an announcement of publication nor a financial summary but the actual ownership report. Therefore, it should be classified as MRQ.
2026-04-10 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Capital/Financing Update Classification · 1% confidence The document is a Korean voluntary disclosure (“자율공시”) detailing the issuance results of the company’s 37th series non‐guaranteed convertible bonds – including issuance amount, board resolution date, and payment date. This is a direct update on the company’s financing activity. Therefore, it falls under Capital/Financing Update (CAP).
2026-04-09 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a Korean regulatory filing titled “주요사항보고서(유상증자결정)” (Major Event Report – Paid-in Capital Increase Decision) with details of a share issuance (유상증자), including correction of the listing date, number of new shares, issuance method, allotment details and the use of funds. This clearly describes a new share issue/capital change, fitting our category for share issues. Therefore, it should be classified under Share Issue/Capital Change (SHA).
2026-04-09 Korean
[기재정정]주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a Korean "주요사항보고서(감자 결정)" (Major Matters Report on Capital Reduction), detailing a correction to the previously filed capital reduction announcement: revised pre- and post-reduction capital, share counts, reduction ratios, and effective dates. It is not an annual or interim financial report, earnings release, call transcript, or proxy statement. It specifically relates to a change in the company’s capital structure (reduction of capital and share count), which falls under "Share Issue/Capital Change." Hence, it is classified as SHA.
2026-04-09 Korean
기타경영사항(자율공시)
Legal Proceedings Report Classification · 1% confidence The document is a voluntary corporate disclosure (자율공시) by Dongsung Pharmaceutical announcing the immediate appeal (‘즉시항고’) against a court’s rehabilitation plan approval decision. This is clearly an update on significant legal proceedings rather than a financial report, management change, or other categories. It fits the “Legal Proceedings Report” category (LTR).
2026-04-08 Korean
매출채권이외의채권에서발생한손상차손
Regulatory Filings Classification · 1% confidence The document is a standalone disclosure on KRX detailing an impairment loss on non-trade receivables, with tables of figures and reference to the company’s audit report submission. It is not a full Annual or Interim Report, nor an earnings release, M&A, dividend notice, management change, or other specific category. Therefore, it falls into the general “Regulatory Filings” category as a miscellaneous regulatory announcement.
2026-04-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.